These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3544654)

  • 1. The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo.
    Schrader H; Kayed K; Bendixen Markset AC; Treidene HE
    Acta Neurol Scand; 1986 Oct; 74(4):297-303. PubMed ID: 3544654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
    Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
    Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant drugs for narcolepsy.
    Vignatelli L; D'Alessandro R; Candelise L
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003724. PubMed ID: 16034909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placebo.
    Bitsch M; Skrumsager BK
    Int J Obes; 1987; 11(2):183-90. PubMed ID: 3301710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF
    Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison.
    Skrumsager BK; Jeppesen K
    Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. So-called "tension headache"--the response to a 5-HT uptake inhibitor: femoxetine.
    Sjaastad O
    Cephalalgia; 1983 Mar; 3(1):53-60. PubMed ID: 6850822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study.
    Andersson PG; Petersen EN
    Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and polygraphic effects of d.1 5 HTP on narcolepsy-cataplexy.
    Autret A; Minz M; Beillevaire T; Degos C; Cathala HP
    Biomedicine; 1977 Jul; 27(5):200-3. PubMed ID: 336110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J; Tamminen T; Elosuo R; Manniche PM
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selegiline in the treatment of narcolepsy.
    Hublin C; Partinen M; Heinonen EH; Puukka P; Salmi T
    Neurology; 1994 Nov; 44(11):2095-101. PubMed ID: 7969965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
    Scrima L; Hartman PG; Johnson FH; Thomas EE; Hiller FC
    Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
    Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
    Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.
    Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
    Lammers GJ; Arends J; Declerck AC; Ferrari MD; Schouwink G; Troost J
    Sleep; 1993 Apr; 16(3):216-20. PubMed ID: 8506453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.
    Warrington SJ; Turner P; Skrumsager BK
    Br J Clin Pharmacol; 1989 Mar; 27(3):343-51. PubMed ID: 2719894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of narcolepsy with codeine.
    Fry JM; Pressman MR; DiPhillipo MA; Forst-Paulus M
    Sleep; 1986; 9(1 Pt 2):269-74. PubMed ID: 3518019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.